SEC Filings for BioXcel Therapeutics Inc. (BTAI)

$ 42.00 r      -1.11 (-2.57%) Volume: 121.22k 11:09 AM EDT Sep 22, 2020
Filing Type:
Form TypeForm DescriptionPagesDateView
8-KCurrent report pursuant to Section 13 or 15(d)1308/14/2020
10-QGeneral form for quarterly reports under Section 13 or 15(d)14208/14/2020
8-KCurrent report pursuant to Section 13 or 15(d)5907/31/2020
424B5Prospectus [Rule 424(b)(5)]6107/31/2020
S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuers7807/27/2020
8-KCurrent report pursuant to Section 13 or 15(d)407/27/2020
424B5Prospectus [Rule 424(b)(5)]6007/27/2020
8-KCurrent report pursuant to Section 13 or 15(d)306/24/2020
4Statement of changes in beneficial ownership of securities106/23/2020
3Initial statement of beneficial ownership of securities306/23/2020
3Initial statement of beneficial ownership of securities306/17/2020
4Statement of changes in beneficial ownership of securities106/17/2020
4Statement of changes in beneficial ownership of securities105/28/2020
4Statement of changes in beneficial ownership of securities305/28/2020
4Statement of changes in beneficial ownership of securities305/28/2020
<<
First
<
Prev
123456789101112